The germ-cell lineage ensures the continuity of life through the generation of male and female gametes, which unite to form a totipotent zygote. We have previously demonstrated that, by using cytokines, embryonic stem cells and induced pluripotent stem cells can be induced into epiblast-like cells (EpiLCs) and then into primordial germ cell (PGC)-like cells with the capacity for both spermatogenesis and oogenesis 1, 2 , creating an opportunity for understanding and regulating mammalian germ-cell development in both sexes in vitro. Here we show that, without cytokines, simultaneous overexpression of three transcription factors, Blimp1 (also known as Prdm1), Prdm14 and Tfap2c (also known as AP2c), directs EpiLCs, but not embryonic stem cells, swiftly and efficiently into a PGC state. Notably, Prdm14 alone, but not Blimp1 or Tfap2c, suffices for the induction of the PGC state in EpiLCs. The transcription-factor-induced PGC state, irrespective of the transcription factors used, reconstitutes key transcriptome and epigenetic reprogramming in PGCs, but bypasses a mesodermal program that accompanies PGC or PGC-like-cell specification by cytokines including bone morphogenetic protein 4. Notably, the transcription-factor-induced PGC-like cells contribute to spermatogenesis and fertile offspring. Our findings provide a new insight into the transcriptional logic for PGC specification, and create a foundation for the transcription-factorbased reconstitution and regulation of mammalian gametogenesis.
3
. Gene-knockout studies have identified transcription factors (TFs) essential for PGC specification 3 . However, the TFs sufficient for PGC induction and the precise mechanism of action of key TFs remain unknown. Using the in vitro PGC specification system 1, 2 , we set out to identify TFs whose forced expression may be sufficient to confer the PGC fate onto EpiLCs. We focused on the three TFs BLIMP1 (hereafter referred to as B), PRDM14 (P14) and TFAP2C (A) because they show specific expression in PGCs and are necessary for PGC specification [4] [5] [6] [7] . We derived embryonic stem (ES) cells expressing mVenus and enhanced cyan fluorescent protein (eCFP) under the control of Blimp1 and stella (also known as Dppa3 and PGC7) regulatory elements, respectively (Blimp1-mVenus (BV) and stella-eCFP (SC), or BVSC) 1, 2, [8] [9] [10] , and reverse tetracycline transactivator (rtTA) under the control of the constitutively active Rosa26 locus 11 (BVSCR26rtTA ES cells) (Fig. 1a) . During mouse development, Blimp1 expression signifies the onset of PGC specification, whereas stella begins expression in the established PGCs 5, 8, 9 . We transfected the BVSCR26rtTA ES cells (XY karyotype) ( Supplementary Fig. 1a -c) with piggyBac transposon-based vectors expressing Blimp1, Prdm14 or Tfap2c under the control of tetracycline regulatory elements to isolate BVSCR26rtTA ES cells bearing transgenes for all three TFs (BP14A), or two (BP14, BA and P14A) or one (B, P14 and A) of the three TFs ( Fig. 1a and Supplementary Fig. 1d , e).
We first examined the effect of simultaneous forced expression of the three TFs. We induced BP14A cells (line 3-3) into EpiLCs, and generated floating aggregates of ,2,000 EpiLCs in the absence of relevant cytokines with or without doxycycline (Dox; 1.5 mg ml 21 ), a tetracycline analogue ( Supplementary Fig. 2a ). The aggregates without Dox did not show BVSC expression over the six-day period (Fig. 1b) . By contrast, remarkably, those with Dox exhibited robust BVSC expression as early as day 2 of the Dox treatment (Fig. 1b) . We confirmed that Dox induces exogenous TFs rapidly and at high levels in nearly all EpiLCs (Supplementary Fig. 2b , c). Fluorescence activated cell sorting (FACS) revealed that at day 2, more than ,80% and ,30% of the cells expressed BV and SC, respectively (Fig. 1c) , and the efficiency of BVSC induction was dependent on the Dox dosage ( Supplementary Fig. 2d , e). The BVSC induction by Dox was much more efficient/faster than that by the cytokines 1,2 ( Supplementary Fig. 2f ). The Dox-induced BVSC-positive cells showed proliferation and persisted until day 4, but decreased thereafter ( Fig. 1b and Supplementary Fig. 2g ). The other BP14A lines showed similar BVSC induction by Dox ( Supplementary Fig. 3a, b) . As in the case of the induction by cytokines 1 , the Dox-induced EpiLCs adhering to the culture dish tended to detach, and the remaining cells did not activate BVSC as efficiently (data not shown). Thus, under the floating aggregate condition, the three TFs are sufficient for robust activation of the BVSC transgenes in EpiLCs.
We analysed the expression of genes relevant for PGC specification in TF (BP14A)-induced BV-positive cells (including SC-positive cells; Fig. 1c ) by quantitative PCR (qPCR). Like cytokine-induced BV-positive cells, TF-induced BV-positive cells upregulated key genes for PGC specification/development (Blimp1, Prdm14, Tfap2c, Nanos3, stella, Pou5f1, Sox2 and Nanog) and downregulated epigenetic modifiers (Dnmt3a and Dnmt3b) 1 (Fig. 1d) . Interestingly, unlike cytokine-induced cells and PGCs in vivo 1, 8, 12, 13 , TF-induced cells did not show transient upregulation of mesodermal genes such as Hoxa1, Hoxb1 and T (also known as brachyury), but continued to express them at low/undetectable levels ( Fig. 1d and Supplementary Fig. 3d ), indicating that the TF (BP14A)-induced BV-positive cells acquire a transcriptional program similar to PGCs, but lack a mesodermal program.
We next examined whether the forced expression of two or one of the three TFs would induce BVSC (three lines for each). We found that P14A, and to a lesser extent, BP14 and BA, and, notably, P14 alone, activated BVSC, although all at lower efficiencies than all three TFs combined (BP14A) ( Supplementary Fig. 3a-c) . The BA-induced aggregates (two out of three lines) looked fragile and remained small (Supplementary Fig. 3a) , and B or A alone did not activate BVSC ( Supplementary  Fig. 3a-c) . We confirmed that all the lines showed uniform induction of exogenous TF(s) after Dox treatment ( Supplementary Fig. 4a-f ). It should be noted that we could not isolate B cells that express exogenous Blimp1 after Dox treatment at levels as high as those of exogenous Prdm14 in P14 cells ( Supplementary Fig. 4c-e) . The two TFs (P14A, BP14, BA)-and single TF (P14)-induced BV-positive cells (including SC-positive cells ( Supplementary Fig. 3c )) exhibited gene expression dynamics similar to those of BP14A-induced BV-positive cells ( Fig. 1d and Supplementary Fig. 4g ), suggesting that once the key regulators for PGC specification is activated, the induced cells acquire similar transcriptional profiles. We determined the relationship between the BVSC induction rate and the exogenous TF expression level. As shown in Fig. 1e (data based on Supplementary Figs 3b and 4c ), BP14A induced BVSC much more efficiently than P14A or BA or P14 at similar whole exogenous TF levels, indicating that BP14A shows a synergistic effect on the activation of PGC-like transcriptional profiles in EpiLCs.
To exclude the possibility that the TFs activate BMP4 signalling, which in turn induces EpiLCs into a PGC-like state, we induced BP14A in EpiLCs with an inhibitor for BMP4 signalling-LDN193189, which inhibits activin receptor-like kinase 2/3. LDN193189 blocked BV, Blimp1 and Prdm14 induction by BMP4, but not by BP14A (Supplementary Fig. 5a, b) . These findings, together with the much faster kinetics of BVSC induction by the TFs than by the cytokines (Fig. 1b and Supplementary Fig. 2f ), indicate that the TFs directly activate a PGC program. We then examined whether induction of a PGC-like state by TFs requires an EpiLC state. Although BP14A induced EpiLCs robustly into a PGClike state, BP14A induction in ES cells resulted in a peculiar phenotype: intense SC activation with no BV (Supplementary Fig. 5c, d ), demonstrating that a proper cellular context (for example, a proper epigenetic background, presence/absence of trans-acting factors) is essential for the robust induction of a PGC-like state by TFs.
To characterize further the TF-induced PGC-like cells (hereafter referred to as TF-PGCLCs), we determined their transcriptomes (BVpositive cells (including SC-positive cells) induced by BP14A (days 2 and 4), BP14 (day 2), P14A (day 2) and P14 (day 2) ( Supplementary  Fig. 6a) ) and compared them with those of PGCs at embryonic day (E) 9.5 (ref. 1) and cytokine-induced day 2, 4 and 6 PGCLCs (hereafter referred to as Ck-PGCLCs) 1 . Principal component analysis (PCA) revealed that all the TF-PGCLCs, irrespective of the TF combinations or of the induction period, bear similar transcriptomes, which are also similar to the transcriptomes of day 4 and 6 Ck-PGCLCs and, to a lesser extent, of E9.5 PGCs (Fig. 2a and Supplementary Table 1 ), indicating that the exogenous TFs, at varying efficiencies depending on their combinations, creates a similar PGC-like transcriptome. Notably, day 2 Ck-PGCLCs showed a more similar transcriptome to E5.75 epiblasts than to TF-PGCLCs, day 4 and 6 Ck-PGCLCs, and E9.5 PGCs, indicating that day 2 Ck-PGCLCs represent a transient state towards the acquisition of a PGC-like state from the EpiLC/epiblast states (Fig. 2a) . The transcriptomes of the SC-positive cells induced by BP14A in ES cells (SC ES cells by BP14A) (Supplementary Fig. 5c, d ) were different from those of PGCLCs/PGCs, and closer to those of ES cells (Fig. 2a) .
We looked at individual genes upregulated in day 2 TF (BP14A)-PGCLCs in comparison to those in EpiLCs/control EpiLCs without exogenous TFs but treated with Dox, and found that genes such as Blimp1, Prdm14, Tfap2c, stella, Sox2, Klf2, Tcl1, Esrrb, Elf3, Kit, Lifr, Nr5a2, Gjb3, Tdh, Spnb3, Pygl, Mbp, Npnt and AU015386 showed robust upregulation. All of these genes ('core PGC genes') were upregulated in day 4 and 6 Ck-PGCLCs and in E9.5 PGCs ( Supplementary  Fig. 6b, Supplementary Table 2) . We examined the genes upregulated in day 2 Ck-PGCLCs but not in day 2 TF-PGCLCs in comparison to those in EpiLCs, which revealed that the genes Hoxa1, Hoxb1, Hoxb2, Evx1, T, Cdx1, Cdx2, Hand1, Snai1, Mesp1, Id1, Msx1, Msx2, Nkx1-2, Isl1, Mixl1, Rspo3, Wnt5a, Fgf8 and Bmp4-all of which show transient upregulation in PGC precursors at around E7.0 and represent a somatic 
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LETTER RESEARCH mesodermal program 13 -were transiently upregulated in day 2 Ck-PGCLCs but not in day 2 TF-PGCLCs, and most of these genes were downregulated in day 4 and 6 Ck-PGCLCs and in E9. Table 3 ). These findings demonstrate on a genome-wide scale that PGC/PGCLC specification by BMP4 activates both a key PGC program and a somatic mesodermal program, the latter of which is eventually repressed by the former, and that the direct activation of key TFs confers EpiLCs with the key PGC program but not the somatic mesodermal program.
We evaluated the epigenetic profiles of TF-PGCLCs. Compared to EpiLCs showing high DNMT3B, BV-positive day 4 TF-PGCLCs were extremely weak for DNMT3B and showed reduced histone H3 lysine 9 di-methylation (H3K9me2) and increased H3K27 tri-methylation (H3K27me3) ( 
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TF-PGCLCs retained the imprints on paternally imprinted H19 and maternally imprinted Snrpn (Fig. 3c) . These findings suggest that the BV-positive day 4 TF-PGCLCs acquire an epigenome similar to day 6 Ck-PGCLCs and to migrating PGCs at E8.5-E9. 5 (refs 1, 14) .
We went on to gain insights into the targets of the three TFs. The induction kinetics by the TFs of endogenous Blimp1, Prdm14 and Tfap2c in whole EpiLC aggregates showed that (1) BLIMP1 and PRDM14 activate Blimp1 gradually and Tfap2c rapidly, whereas TFAP2C does not activate Blimp1 nor Tfap2c, but enhances the activity of BLIMP1 to induce Tfap2c and Blimp1; (2) activation of Prdm14 by the TFs occurs relatively late (after 24 h); and (3) BP14A has the strongest effect on the activation of Blimp1, Tfap2c and subsequently Prdm14 (Supplementary Fig. 8) . We determined the transcriptomes induced by the TFs at 24 h in whole EpiLC aggregates. Unsupervised hierarchical clustering and PCA showed that PRDM14 alone induces a transcriptome similar to that induced by BP14A (Fig. 3a, Supplementary Fig. 9a and Supplementary Table 4) . Accordingly, Gene Set Enrichment Analysis (GSEA) 15 showed that core PGC genes are enriched in genes induced by PRDM14 and, to a lesser extent, in genes induced by BLIMP1, but show no significant enrichment in genes induced by TFAP2C (Fig. 3b) . Thus, PRDM14 has a central role in the BP14A-induced PGCLC formation.
We analysed individual genes regulated by PRDM14 and BLIMP1 with regard to the regulation of corresponding genes by BP14A. We classified the genes regulated by PRDM14 and BLIMP1 into those regulated in the same (a) (up or down by both P14 and B) and opposite (b) (up by P14 and down by B, or vice versa) direction. This revealed a trend in which the expression-level changes of the type (a) genes were enhanced ( Fig. 3c and Supplementary Fig. 9b-d) , whereas the type (b) genes were 'balanced' (Supplementary Fig. 9e, f) by BP14A. Importantly, the core PGC genes were overrepresented by genes upregulated by both PRDM14 and BLIMP1 (Fig. 3c) . We scrutinized individual genes up-/ downregulated by PRDM14 and BLIMP1. We found that PRDM14 upregulates genes associated with pluripotency (such as Epas1, Tcl1, Esrrb, Klf5, Nr5a2, Zfp42, Klf4, Lifr, Dppa2, Dppa5a and Nanog), and downregulates genes associated with neural differentiation (Zfp521, Sox3, Nrcam and Hs6st2). Although we did not find a clear functional category of genes upregulated by BLIMP1, we noted that BLIMP1 represses targets of OCT4 and SOX2 (Fgf4, Lefty1 and Lefty2), among others ( Supplementary Fig. 9c-f and Supplementary Table 5 ). Some of the targets of PRDM14 were in common between ES cells and EpiLCs (upregulated: Tcl1, Esrrb and Klf5; downregulated: Hs6st2 and Dnmt3b) 16 ( Supplementary Fig. 9c-f ). These findings reveal that PRDM14 and BLIMP1 function primarily and co-operatively, whereas TFAP2C has an auxiliary role, at least for BLIMP1, for the acquisition of the TF-PGCLC transcriptome. The finding that BLIMP1 makes a relatively small contribution to the TF-PGCLC transcriptome would be attributable to TF-PGCLCs lacking the cytokine-induced somatic mesodermal program, which BLIMP1 has an essential role in repressing 13 . After Dox withdrawal, the TF-PGCLCs shut off exogenous TFs, but continue their endogenous transcription program, and may therefore serve as precursors for proper spermatogenesis. To explore this possibility, we induced TF-PGCLCs (BP14A, BP14, P14A, P14), purified the BV-positive cells (including SC-positive cells, at days 3, 4 and 6) ( Fig. 4a and Supplementary Table 6), and transplanted them into seminiferous tubules of neonatal W/W v mice lacking endogenous germ cells 1, 17 . Notably, ten weeks after transplantation, the testes transplanted with the TF-PGCLCs, particularly those sorted at days 3 and 4, irrespective of the TFs used, contained numerous tubules with signs of spermatogenesis (Fig. 4b, Supplementary Fig. 10a and Supplementary Table 6 ). These tubules showed normal spermatogenesis and contained spermatozoa with proper morphology (Fig. 4c, d and Supplementary Fig. 10b ). The control day 6 Ck-PGCLCs also contributed to spermatogenesis (Supplementary Table 6 ). By contrast, SC ES cells induced by BP14A did not contribute to spermatogenesis, but formed foci of teratomas in six out of eight transplanted testes ( Supplementary Fig. 10d , e and Supplementary Table 6 ). The inability of day 6 TF-PGCLCs to contribute to spermatogenesis may result from a prolonged non-optimal culture of TF-PGCLCs (Supplementary Table 6 ). We fertilized wild-type oocytes with TF-PGCLC-derived spermatozoa by intracytoplasmic sperm injection 18 . The resultant zygotes developed into two-cell embryos, and we transferred these embryos into pseudopregnant female mice, and 18 days later, obtained healthy offspring with grossly normal placenta and imprinting states (Fig. 4e-h, Supplementary Fig. 10c , f and Supplementary Table 7 ). These offspring bore transgenes for the exogenous TFs and the BVSCR26rtTA (Supplementary Fig. 10g ), and grew up normally into fertile adults (Fig. 4i, Supplementary Fig. 10h , i and Supplementary Table 7) . We conclude that the TF-PGCLCs function as bona fide precursors for the spermatogenesis and healthy offspring.
We have demonstrated the transcriptional logic by which BLIMP1, PRDM14 and TFAP2C activate a key PGC program and create the TFPGCLCs (Fig. 4j) . On the basis of our findings, it should be feasible to e, Zygotes at pronuclear stages generated by injection of TF-PGCLC-derived spermatozoa into wild-type oocytes by intracytoplasmic sperm injection. f, Two-cell embryos from zygotes in e. g, h, Apparently normal offspring (g, h) and placenta (g) derived from TF-PGCLC-derived spermatozoa. i, A fertile female derived from a TF-PGCLC-derived spermatozoon. j, A proposed model for TF-PGCLC induction.
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explore TF-based regulation of further crucial processes of germ-cell development. The TF-based control of germ-cell development may be applicable to mammals other than mice, including humans.
METHODS SUMMARY
BVSCR26rtTA ES cells were established and maintained under the N2B27 '2i 1 LIF' condition 19 . PB-TET vectors 20 with Avi-Blimp1, 33FLAG-Prdm14 and V5-Tfap2c (Supplementary Table 8 ) were transfected into the BVSCR26rtTA ES cells (XY karyotype) on feeders with Lipofectamine2000 (Invitrogen) together with pPBCAG-hph and pCAGGS-mPB plasmids. Transgene integration was determined by PCR and Southern blotting. Transfected ES cells were adapted to a feeder-free condition and differentiated into EpiLCs as reported 1 . After 36 h of differentiation, cells were aggregated (2,000 cells per aggregate) in GK15 medium 1 with Dox (1.5 mg ml 21 ) (Clonetech). Ck-PGCLCs were induced by BMP4, BMP8A, SCF, LIF and EGF as described 1 . Transcriptomes were analysed by GeneChip Mouse Genome 430 2.0 Array (Affymetrix) 1, 21 . Published data (Gene Expression Omnibus (GEO) accessions GSM744093-GSM744096 and GSM744099-GSM744104) 1 were included in the analysis. Seminiferous tubule injection and intracytoplasmic sperm injection were performed as described 1, 17, 18 . All primer sequences for PCR are listed in Supplementary Table 9 .
Full Methods and any associated references are available in the online version of the paper. Col1a1 tm2(tetO-Pou5f1)Jae /J mice heterozygous for both loci. They were mated with BVSC transgenic mice and blastocysts were recovered at E2.5. BVSC-R26rtTA ES cells were selected by PCR genotyping, and established and maintained under the N2B27 '2i 1 LIF' condition 19 . A male cell line was used in this study. Chimaera formation assay. BVSC-R26rtTA ES cells were trypsinized and a singlecell suspension was prepared. Approximately 15 ES cells per embryo were injected into blastocoels of E3.5 blastocysts obtained from ICR (albino) female mice with a piezo-actuating micromanipulator. Injected embryos were transferred into the uteri of E2.5 pseudopregnant ICR female mice. Chimaeric mice were delivered by caesarean section at E18.5. Chimaerism was determined by coat-colour. The chimaeric mice were subjected to test breeding with ICR female mice to confirm the germ-line contribution. Vector construction. The mouse Blimp1 (from ATG in exon 3) and Tfap2c variant 1 (accession number: NM_009335.2) coding sequences were cloned by PCR flanked with SalI-AviTag-XhoI and NotI sites and NotI and EcoRI sites, respectively. The Prdm14 coding sequence was obtained from AG-P14 (ref. 16 ).
METHODS
The SalI-Avi-Blimp1-NotI cassette was subcloned into XhoI/NotI sites of the pPyCAG-cHA-IP plasmid 22 , and this cassette was subcloned again into the EcoRI/ NotI sites of the pENTR1A dual selection vector (Invitrogen). For Prdm14 and Tfap2c, KpnI-33FLAG-XhoI-S(G4S) 3 _Linker-SpeI and BamHI-V5-S(G4S) 3 _Linker-NotI fragments, respectively, were attached to the amino termini by PCR or synthesized oligonucleotide linker ligation. 33FLAG-Prdm14 and V5-Tfap2c cassettes were subcloned into the KpnI/NotI and BamHI/EcoRI sites of pENTR1A, respectively. Lastly, they were shuttled into the PB-TET destination vector (Addgene) 20 with LR clonase II enzyme mix (Invitrogen). To construct pPBCAG-hph, a CAG promoter fragment from the pCAGGS plasmid obtained by digestion of SpeI and EcoRI (filled) was inserted into the GG131 vector 23, 24 digested with SpeI/MscI. All sequences engineered by PCR or oligonucleotide synthesis were confirmed. All attached sequences are shown in Supplementary Table 8 and primer sequences for cloning  are listed in Supplementary Table 9 . Transfection and selection of subclones. BVSC-R26rtTA ES cells were transfected with PB-TET vectors containing key factors, pPBCAG-hph and pCAGGS-mPB using Lipofectamine2000 (Invitrogen) on feeder cells (mouse embryonic fibroblasts) in a 60-mm dish under a 2i 1 LIF condition. The total amount of vector DNA was below 8 mg. Transfectants were selected with hygromycin B (150 mg ml 21 ) (Sigma) and genotyped with PCR for transgenes. The primer sequences for the genotype are shown in Supplementary Table 9 . Southern blotting. Eight micrograms of genomic DNA was isolated and digested with BamHI. DNA fragments were electrophoresed in 0.7% agarose gel, transferred to Hybond N 1 (GE Healthcare) and ultraviolet-crosslinked. The b-geo probe was obtained by digestion of PB-TET with RsrII/SmaI, labelled with 32 P (PerkinElmer) by a random primer DNA labelling kit ver. 2.0 (TaKaRa) and purified with an Illustra ProbeQuant spin column (GE Healthcare). Radioisotope images were captured with a BAS system (Fujifilm). Karyotyping. Metaphase chromosome spreads of ES cells were prepared by treating them with demecolcin solution (0.03 mg ml
21
) for 2 h at 37 uC, followed by hypotonic treatment with 75 mM potassium chloride for 15 min at room temperature. Cells were fixed in Carnoy's solution (3:1 mixture of methanol and acetic acid) and dropped onto glass slides soaked in 50% ethanol before the analysis. The presence of the Y chromosome was determined by PCR with UbeI primers. Cell lines including 2-4, 7-1, 7-5 and 7-8 were found to have the XO karyotype. The primer sequences are described in Supplementary Table 9 . TF-and Ck-PGCLCs. Transfected ES cells were adapted to a feeder-free condition before induction. EpiLC differentiation was performed as reported previously 1 . After 36 h of differentiation, cells were collected and cultured in a Lipidure-Coat 96-well plate (NOF) to be aggregated (started with 2,000 cells per well) in GK15 (ref. 1) with 1.5 mg ml 21 of Dox (Clonetech). The TF-PGCLCs can be induced as 1,000-5,000 (possibly more) cells per well. We used 2,000 cells per well in this study, as this condition was most efficient for obtaining BVSC-positive TF-PGCLCs. PGCLCs were induced by BMP4 (500 ng ml 21 ), BMP8A (500 ng ml 21 ), SCF (100 ng ml 21 ), LIF (1,000 U ml
) and EGF (50 ng ml 21 ) as previously described 1 . LDN193189 (120pM; Stemgent) was added concurrently with Dox or cytokines. Aggregates from ground-state ES cells were also cultured in GK15 with Dox as described above. Reverse transcription and qPCR. For evaluating endogenous transcripts, TFinduced BV-positive cells were FACS-sorted on days 2 and 4 with the gates shown in Fig. 1c and Supplementary Fig. 3c . The sorting gates used for day 2 and 4 CkPGCLCs are shown in Supplementary Fig. 6a . Aggregates were trypsinized and lysated as a whole unless otherwise specified. Total RNA was purified with an RNeasy Micro kit (QIAGEN) and reverse transcription was performed with SuperScript III (Invitrogen) primed with oligo-dT primer according to the manufacturer's protocol. Real-time PCR was performed with Power SYBR (Applied Biosystems) and CFX384 (BioRad). The gene expression levels are presented as DC t (in log 2 scale) normalized with the average C t values of Arbp and Ppia
.
To discriminate endogenous transcripts from exogenous ones, both the oligodT primer (Invitrogen) and gene-specific primers of interest were used for reverse transcription to reduce the reverse transcription bias due to differences in the distance between reverse transcription priming sites and amplified regions. The amplification efficiency of the newly designed primer sets was determined with pGEM-T-Easy plasmids containing the corresponding amplicons as templates. To verify both the endogenous and exogenous expression levels, samples were tested with CDS primers concurrently (data not shown). We found that the amplification efficiency of the 33FLAG-Prdm14 primer set was slightly lower than that of the other primer sets. Therefore, we adjusted the C t value of 33FLAG-Prdm14 using the equation: cC t(3|FLAG-Prdm14)~1 :017|C t(3|F LAG-Prdm14) {1:039 in which cC t(33FLAG-Prdm14) and C t(33FLAG-Prdm14) are the adjusted C t values and original C t values obtained by the experiment using the 33FLAG-Prdm14 primer set, respectively. This equation was determined by linear regression between the C t(33FLAG-Prdm14) and C t values of the b-geo primer set in cell lines containing 33FLAG-Prdm14 but not the other two TFs (data not shown). In this paper, cC t(33FLAG-Prdm14) was used for calculation of the DC t values for the 33FLAG-Prdm14 primer set.
The primer sequences are listed in Supplementary Table 9 (refs 12, 21) . LacZ staining. Cell aggregates at 12 h were trypsinized and fixed with 2% paraformaldehyde and 0.2% glutaraldehyde. Fixed cells were spread with cytospin4 (Thermo Scientific) and stained with LacZ staining solution overnight 20 . Flowcytometric analysis and cell sorting. The sample preparations from cell aggregates were performed essentially as described previously 1 . FACS was performed with a FACSAria or FACSAriaIII (BD) cell sorter. BV and SC fluorescence were detected with the FITC and AmCyan Horizon V500 channel, respectively. Data were analysed with FACSDiva (BD) or Flowjo (Tree Star) software. Immunofluorescent staining. BV-positive cells from BP14A-induced day 4 aggregates were sorted with the gate shown in Supplementary Fig. 7 , mixed with EpiLCs at a ratio of 1:1 and spread onto MAS-coated glass slides (Matsunami). Immunofluorescent staining was performed as reported previously 1 . The primary antibodies used in this study were as follows: anti-GFP (rat monoclonal antibody; Nacalai Tesque GF_090R), anti-DNMT3B (mouse monoclonal antibody; Imgenex IMG-184A), anti-H3K27me3 (rabbit, polyclonal antibody; Millipore 07-449), and antiH3K9me2 (rabbit, polyclonal antibody, Millipore 07-441). Secondary antibodies were as follows: Alexa Fluor 568 anti-rabbit IgG, Alexa Fluor 488 anti-rat IgG and Alexa Fluor 647 anti-mouse IgG (all three from Invitrogen, A11011, A11006 and A21235, respectively). Images were captured with a confocal laser scanning microscope (Olympus FV1000). Bisulphite sequencing. Genomic DNA was isolated and bisulphite treatment was conducted with an EpiTect bisulphite kit (QIAGEN) according to the manufacturer's protocol. The differentially methylated regions of Snrpn, H19, Igf2r, Peg1 and Peg3 were amplified by PCR as previously reported 25 . Sequences were determined and analysed with QUMA (http://quma.cdb.riken.jp/top/index.html) 26 . cDNA amplification and microarray analysis. For characterization of TFPGCLCs, the cell populations surrounded with red rectangles in Supplementary  Fig. 6a were sorted by FACS. Note that the background level was different in sorting of Ck-PGCLCs and TF-PGCLCs on day 2. Total RNA was isolated with an RNeasy micro kit (QIAGEN) and reverse transcription and cDNA amplification were conducted as previously described 1, 21 . Samples were analysed with a GeneChip Mouse Genome 430 2.0 Array (Affymetrix). Data were normalized with dChip software and are shown in log 2 scale 27 . Probes that exhibited a 'present' call in at least one sample were included in the analysis. Probe selection criteria for further analysis were as follows: (1) maximum expression score $ 8; (2) maximum differential expression level $ 2; and (3) exhibiting the highest expression level among multiple probes for a gene, if any. Published data (GEO accession GSE30056 (two replicates of ES cells (GSM744093 and GSM744094), EpiLCs (GSM744095 and GSM744096), epiblast (GSM744099 and GSM744100), Ck-PGCLCs d6 (GSM744101 and GSM744102), and E9.5 PGCs (GSM744103 and GSM 744104))) LETTER RESEARCH were also included 1 . We selected 4,464 probes and performed PCA with R (version 2.15.1) 28 . For the differential gene expression analysis, we averaged biological duplicates or quadruplicates and selected core PGC genes ( Supplementary Fig. 6b, top) and 'somatic mesodermal genes' (Supplementary Fig. 6b, bottom) according to the following criteria. Core PGC genes were (1) upregulated in BP14A-induced day 2 more than fourfold compared with both EpiLCs and the parental clone with Dox day 2; and (2) not downregulated in E9.5 PGCs (the expression level was not less than a half of BP14A-induced day 2). Somatic mesodermal genes exhibited at least fourfold upregulation in day 2 PGCLCs as compared with both EpiLCs and BP14A-induced day 2. Representative genes are specified. The complete list is shown in Supplementary Table 2 . To compare the genes whose expression was altered by BP14A between EpiLCs and ES cells, differences in log 2 scale between the averaged expression value of day 2 TF-PGCLCs and EpiLCs, between that of SC-positive cells induced by BP14A in ES cells and ES cells, and between that of CkPGCLCs day 4 and EpiLCs were calculated. The 100 genes exhibiting the most altered expression in EpiLCs and ES cells are listed in Supplementary Table 3 .
To identify the target genes of each transcription factor, total RNA was isolated with an RNeasy Micro kit (QIAGEN) from both EpiLCs and whole cells from day 1 aggregates on each of the BP14A (line 3-3), B (line 2-4), P14 (line 7-109), and A (line 8-2) cell lines and the parental clone cultured with Dox. Data acquisition with microarray and data normalization was performed as described above. We first selected 38,769 probes that exhibited a present call in at least one sample and performed GSEA 15 with core PGC genes defined above as a gene set. Genes were ranked by the difference of the expression levels (in log 2 scale) between day 1 aggregates and EpiLCs for each cell line. For further analysis, 4,211 probes were selected according to the following criteria: (1) maximum expression score $ 6; (2) maximum differential expression level $ 1; (3) P value of one-way analysis of variance for 10 groups (each group containing two biological replicates) # 0.10 (false discovery rate # 0.10, calculated by the 'qvalue' software package 29 in the program R); and (4) exhibiting the highest expression level among multiple probes for a gene, if any. Unsupervised hierarchical clustering and PCA were performed with R (version 2.15.1) 28 . To identify a gene whose expression was altered by each of the transcription factors, we averaged biological replicates and calculated the differential expression level between day 1 aggregates and EpiLCs in each cell line. The differential expression level of the parental clone was further subtracted (in log 2 scale) from that of the transfected lines to exclude the effects of aggregation formation. We defined a gene exhibiting this value (fold change from the parental clone) $ 1 or # 1 as up-or downregulated by each factor, respectively. The accession number for the microarray data presented in this study is GSE46855 (GEO database).
Seminiferous tubule injection. After the designated cell populations were sorted by FACS, 1 3 10 4 cells per testis were injected into the neonatal testes of W/W v mice (7 days post partum) basically as previously described 17 . Anti-mouse CD4 antibody (50 mg per dose, clone GK1.5; eBioscience or Biolegend) was injected intraperitoneally at day 0, 2 or 4 for immunosuppression as necessary 30 . The transplanted testes were analysed 10 weeks after injection. For haematoxylin and eosin staining, testis samples were fixed with Bouin's solution, embedded in paraffin, and sectioned. Intracytoplasmic sperm injection. Intracytoplasmic sperm injection was performed basically as reported previously 18 . In brief, seminiferous tubules with spermatogenesis colonies were gently minced and a spermatogenic cell suspension was prepared. Spermatozoa were injected into oocytes recovered from BDF1 mice. After in vitro embryo culture, two-cell-stage embryos were transferred into the oviducts of pseudopregnant mice at 0.5 days post coitum (d.p.c.) (ICR). Pups were delivered by caesarean section at 18.5 d.p.c. The primer sequences used for genotyping PCR are described in Supplementary Table 9 .
